XML 143 R23.htm IDEA: XBRL DOCUMENT
v3.20.1

Segment Information | 6 Months Ended | 12 Months Ended
--- | --- | ---
Feb. 29, 2020 | Aug. 31, 2019
Segment Reporting [Abstract] |  |
Segment Information | 16. Segment Information The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and its chief operating decision makers, being the President and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property Licensing and Consumer Products. Licensing revenues are significantly concentrated on one licensee.
|  | IP Licensing |  |  | Consumer Products |  |  | Corporate |  |  | Consolidated Total |
|  | $ |  |  | $ |  |  | $ |  |  | $ |
External revenue |  |  | 69,750 |  |  |  | 99,631 |  |  |  | — |  |  |  | 169,381 |
CoGS |  |  | — |  |  |  | (65,959 | ) |  |  | — |  |  |  | (65,959 | )
Operating expenses |  |  | (300,034 | ) |  |  | (293,487 | ) |  |  | (1,432,156 | ) |  |  | (2,025,677 | )
Segment loss |  |  | (230,284 | ) |  |  | (259,815 | ) |  |  | (1,432,156 | ) |  |  | (1,922,255 | )
Total assets |  |  | 694,684 |  |  |  | 124,412 |  |  |  | 1,167,130 |  |  |  | 1,986,226 |
17. | Segment Information
| The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and its chief operating decision makers, being the president and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The company has identified two reportable segments: Intellectual Property Licensing and Consumer Products. Licensing revenues are significantly concentrated on three licensees.
|  | IP Licensing |  |  | Consumer Products |  |  | Corporate |  |  | Consolidated Total |
External Revenue |  | $ | 198,000 |  |  | $ | 24,610 |  |  | $ | — |  |  | $ | 222,610 |
CoGS |  | $ | — |  |  | $ | (22,893 | ) |  | $ | — |  |  | $ | (22,893 | )
Operating Expenses |  | $ | (1,211,733 | ) |  | $ | (968,947 | ) |  | $ | (2,177,450 | ) |  | $ | (4,358,130 | )
Segment Loss |  | $ | (1,013,733 | ) |  | $ | (967,230 | ) |  | $ | (2,177,450 | ) |  | $ | (4,158,413 | )
Total Assets |  | $ | 645,969 |  |  | $ | 127,396 |  |  | $ | 1,901,854 |  |  | $ | 2,675,219 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration